Atika Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-62,500
Closed -$4.3M 48
2015
Q4
$4.3M Buy
62,500
+35,500
+131% +$2.35M 2.21% 17
2015
Q3
$1.6M Buy
+27,000
New +$1.71M 0.78% 39

Other funds holding BMY

Atika Capital Management's BMY Position: Q1 2016 in Review

Atika Capital Management sold out of Bristol-Myers Squibb (BMY) in Q1 2016, closing a stake of 62,500 shares — an estimated $4.3M sold.

Atika Capital Management first reported a position in BMY in Q3 2015 and held it in 2 quarters. The position peaked at $4.3M in Q4 2015. 1,523 funds tracked by Wall St. Rank hold BMY as of Q1 2016.

  • Atika Capital Management reported no remaining Bristol-Myers Squibb position as of Q1 2016 after selling out during the quarter.
  • Atika Capital Management sold 62,500 Bristol-Myers Squibb shares in Q1 2016, an estimated $4.3M.
  • Atika Capital Management first reported a position in Bristol-Myers Squibb in Q3 2015 and held it in 2 quarters.
  • Atika Capital Management's Bristol-Myers Squibb position peaked at $4.3M in Q4 2015.
  • 1,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2016.

Based on Atika Capital Management's 13F filing for Q1 2016, filed 16 May 2016.